Biomarker screening continuity
Periodic screening within the prescribed interval — metabolic panels, blood pressure monitoring, retinal imaging for diabetic populations.
A Proof of Care attestation pairs a bonded human validator's signature over a physical session with a zero-knowledge proof generated on the participant's own device. Neither part is worth anything alone.
Signed by a certified validator in the same place as the participant. It carries a commitment to the measured value — never the value itself.
Built on the participant's device, proving the committed value satisfies the clinical rule. Observers learn the rule was met, nothing more.
The contract checks that the proof references the same commitment the validator signed, and rejects any pair that diverges.
Each is defined by a clinical rule, an evidence standard and a funding weight. The registry is governed by clinical review, not by token vote.
Periodic screening within the prescribed interval — metabolic panels, blood pressure monitoring, retinal imaging for diabetic populations.
Continuous supply verified against dispensation records, plus structured lifestyle sessions. A ninety-day program cannot be satisfied with one visit.
Antenatal visits, micronutrient supplementation and child growth monitoring — involving family members beyond the primary account holder.
Triage tests at a community node, authorized in advance by a licensed professional. The protocol records completion and the result's category — never the result.
Every registry entry specifiesA maximum attestation latency, a required validator accreditation class, and a funding weight that payer vaults use to compute releases. Adding a milestone needs clinical review — not a redeployment.
Preventive actions create measurable cost avoidance for a specific payer, and that payer will pay a portion of it to have the actions verified.
Actuaries project a cohort's annual cost of care from claims history — ER visits, avoidable admissions, dialysis starts.
The payer specifies adherence or screening improvements and the avoidance they should generate.
Capital enters an Institutional Payer Vault, with LRGN locked against the program's milestones.
Verified attestations release rewards and validator fees; unspent balances return to the payer at contract end.
ModeledA scenario input for planning, not an observed result. It will be replaced by measured performance as program data accumulates.
The adversary is a colluding validator and participant producing attestations for sessions that never happened. Four mechanisms act together.
Any attestation may be re-examined — by an independent validator sent to the same participant, or a consented record query.
Bonded collateral stays locked through a challenge window that lengthens with the milestone's value.
Penalties scale with the square of the mis-attested value, so one large fraud costs more than many small ones.
Accreditation is issued by health authorities. Lose it and you lose the ability to sign at all.
The composite effect is a floor on the cost of fraud relative to its yield.